Capitolis Liquid Global Markets LLC Sells 29,000 Shares of Intuitive Surgical, Inc. $ISRG

Capitolis Liquid Global Markets LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,000 shares of the medical equipment provider’s stock after selling 29,000 shares during the period. Capitolis Liquid Global Markets LLC’s holdings in Intuitive Surgical were worth $19,231,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Kilter Group LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth about $27,000. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. Caitlin John LLC bought a new position in Intuitive Surgical in the 3rd quarter valued at approximately $30,000. Guerra Advisors Inc acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $37,000. Finally, Riggs Asset Managment Co. Inc. boosted its position in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 32 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands da Vinci 5 into cardiac surgery, opening a much larger long-term TAM (management cites a jump from ~17k to ~160k addressable procedures in cleared markets) — a multi-year growth driver for procedure volume and consumables. Read More.
• Positive Sentiment: Completed acquisition of Southern Europe distributor businesses (Italy, Spain, Portugal) shifts da Vinci and Ion sales to direct operations — should improve control of regional sales/service and capture margin/recurring revenue over time. Read More.
• Positive Sentiment: Sell-side momentum: Citigroup upgraded ISRG to Buy and several analysts maintain bullish price targets, supporting upside thesis and sentiment. Read More.
• Positive Sentiment: Recent Q4 results beat consensus (strong revenue and EPS growth), reinforcing recurring-consumables revenue and the upgrade cycle for da Vinci systems. Read More.
• Neutral Sentiment: Analyst consensus shows meaningful upside (Zacks highlights ~29.7% average target upside), but that depends on execution and multiple expansion remaining intact. Read More.
• Neutral Sentiment: Long-form bullish pieces reiterate a multi-year growth story from da Vinci 5, Ion and software/services but don’t change near-term valuation concerns. Read More.
• Negative Sentiment: Cybersecurity incident (phishing-linked breach affecting internal systems) is the immediate catalyst for the share decline — investors will watch for customer impact, data exposure, and remediation costs. Read More.
• Negative Sentiment: Insider selling (recent EVP share sales) and management guidance calling for a deceleration in worldwide da Vinci procedure growth in 2026 could pressure near-term sentiment and valuation. Read More. • Read More.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Raymond James Financial upped their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. BTIG Research reiterated a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a report on Friday, January 23rd. Royal Bank Of Canada boosted their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Robert W. Baird lowered their target price on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research report on Friday, January 23rd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $615.86.

Intuitive Surgical Stock Down 1.5%

Shares of NASDAQ ISRG opened at $472.16 on Friday. The company has a market capitalization of $167.68 billion, a PE ratio of 59.84, a P/E/G ratio of 3.64 and a beta of 1.66. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The firm has a fifty day simple moving average of $513.26 and a 200 day simple moving average of $512.67.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the sale, the senior vice president owned 3,554 shares in the company, valued at $1,772,308.72. This represents a 39.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 33,407 shares of company stock valued at $17,534,067 over the last 90 days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.